12 Sep 2023
Lisata Therapeutics Announces First Pati ...
Phase 2a double-blind, placebo-controlled, multi-center, randomized study evaluating LSTA1 in combination with standards of care v ...
Get access to the latest news, guides, stock and crypto updates, and take your financial portfolio to the next level.